Disease burden, monitoring strategy, and timing of therapy drive CRS risk and management.
Allison Yang, PharmD
Advertisement
Articles by Allison Yang, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
3
Serologic Immunity to Hepatitis A and B Remains Low Among US Adults
4
Long COVID in the Pharmacy: Recognition, Referral, and the Role of Vaccination
5